Results 161 to 170 of about 35,072 (188)

Adalimumab

Reactions Weekly, 2018
  +4 more sources

Adalimumab

Reactions Weekly
  +6 more sources

Adalimumab

Reactions Weekly, 2016
  +4 more sources

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial

Journal of Investigative Dermatology, 2022
G E Van Der Kraaij, C I Busard, S P Menting   +2 more
exaly  

Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

British Journal of Clinical Pharmacology, 2015
David Ternant, Emilie Ducourau, Hervé Watier   +2 more
exaly  

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Arthritis & Rheumatism, 2006
F. Breedveld, M. Weisman, A. Kavanaugh, S. Cohen, K. Pavelka, R. V. van Vollenhoven, J. Sharp, John L. Perez, G. Spencer-Green   +8 more
semanticscholar   +1 more source

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Journal of Pharmaceutical and Biomedical Analysis, 2013
Emil Chuang, Sharat Singh
exaly  

Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial

Therapeutic Advances in Gastroenterology, 2020
Xiang Gao, Jie Zhong, Jianlin Ren
exaly  

Adalimumab

Reactions Weekly, 2008
openaire   +1 more source

Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology, 2014
Xavier Roblin, Hubert Marotte, Emilie Del Tedesco   +2 more
exaly